Defining Progression Free Survival After Multiple Lines of Therapy and Impact of Dynamic Changes in FLIPI for Multiply Relapsed Follicular Lymphoma in the Rituximab Era Treated at Memorial Sloan Kettering Cancer Center (MSKCC)
暂无分享,去创建一个
V. Seshan | A. Zelenetz | S. Horwitz | A. Younes | J. Gerecitano | P. Hamlin | A. Alperovich | M. Palomba | M. Matasar | C. Moskowitz | Anita Kumar | A. Noy | C. Portlock | D. Straus | A. Moskowitz | P. Drullinsky | P. Caron | Z. Ying | C. Batlevi | A. Hamilton | Katy Smith